Skip to content
    F-Prime Capital logo

    F-Prime Capital

    Cambridge, Massachusetts, United StatesFounded 1969

    F-Prime Capital is a global venture capital firm that primarily invests in healthcare and technology sectors. Within healthcare, they focus on therapeutics, medtech, and healthtech + services, while their technology investments span enterprise software, fintech, frontier tech, and crypto. The firm is generally an early-stage investor but is stage-agnostic, supporting exceptional teams at any stage of growth.

    32% of their portfolio is in Healthcare. Average disclosed round size is $60.9M (across 131 rounds with reported amounts).

    Find people at F-Prime Capital on Goldilocks AI

    Portfolio

    135

    Fund Size

    $4.5B

    Top Stage

    Series A

    Last 12 Mo

    22

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    135 investments
    CompanyRoundAmountDate
    Immutrin logoImmutrinSeries A$87MMar 2026
    R1 Therapeutics logoR1 TherapeuticsSeries A$77.5MMar 2026
    Jump logoJumpSeries B$80MFeb 2026
    MMonarkSeries A$8.1MFeb 2026
    Monark Markets logoMonark MarketsStrategic$8.1MFeb 2026
    Tenpoint Therapeutics logoTenpoint TherapeuticsSeries B$85MJan 2026
    UUnbox RoboticsSeries B$28MJan 2026
    Meld logoMeldSeries A$7MJan 2026
    Paradigm Health logoParadigm HealthSeries B$78MDec 2025
    WellBeam logoWellBeamSeries A$10MNov 2025
    TT-TherapeuticsSeries A$91MNov 2025
    AABK Biomedical, Inc.Series D$35MOct 2025
    Kanastra logoKanastraSeries B$30MOct 2025
    AmplifyMD logoAmplifyMDSeries B$20MSep 2025
    Dispatch logoDispatchSeries A$18MSep 2025
    Charm Therapeutics logoCharm TherapeuticsSeries B$68.5MSep 2025
    ARTBIO logoARTBIOSeries B$132MJul 2025
    Spinwheel logoSpinwheelSeries A$30MJun 2025
    Canary logoCanarySeries D$80MJun 2025
    Canary Technologies logoCanary TechnologiesSeries D$80MJun 2025
    Axle Health logoAxle HealthSeries A$10MMay 2025
    Toku logoTokuSeries A$48MApr 2025
    Galatea Bio Inc logoGalatea Bio IncUnknown$25MMar 2025
    Atalanta Therapeutics logoAtalanta TherapeuticsSeries B$75MJan 2025
    Tenvie Therapeutics logoTenvie TherapeuticsSeries A$200MJan 2025
    Page 1 of 6

    Top Co-Investors

    Last updated: 12 April 2026